IPO - Rhythm Biosciences Limited, page-121

Early detection is key to survival? If current, non-invasive screening methods have a 38% uptake. How can you expect any higher from the painful, inconvenience of a blood test? Surely the FIT is the more favourable option, except for the few strawpeople who can't stomach providing a stool sample. That approximately 27 million m/c is also pretty high for a technology which actually provides marginal benefits in terms of early detection compared with the current tests used and is only just as good for later detection.